SELECT PUBLICATIONS
Alberts SR et al. Systemic capecitabine and oxaliplatin administered with hepatic arterial
infusion (HAI) of floxuridine (FUDR) following complete resection of colorectal
metastases (M-CRC) confined to the liver: A North Central Cancer Treatment Group
(NCCTG) phase II Intergroup trial. Proc ASCO 2006;Abstract 3525.
De Gramont A et al. Oxaliplatin/5-FU/LV in adjuvant colon cancer: Results of the international
randomized mosaic trial. Proc ASCO 2003;Abstract 1015.
Hochster HS et al. Safety and efficacy of bevacizumab (Bev) when added to oxaliplatin/
fluoropyrimidine (O/F) regimens as first-line treatment of metastatic colorectal cancer
(mCRC): TREE 1 & 2 Studies. Proc ASCO 2005;Abstract 3515.
